Enlivex
Lior Binder is an experienced clinical study director currently working at Enlivex Therapeutics since January 2019. Prior to this role, Lior Binder served as a senior clinical operations study manager at OPKO Biologics Ltd. from June 2010 until January 2023.
This person is not in any offices
Enlivex
Enlivex's mission is to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy. As a clinical-stage company focused on specialized cell immunotherapy, Enlivex intends to develop and commercialize an allogeneic drug pipeline for rebalancing all manner of immune hyper-responses.